@EU_Startups
Brenus Pharma, a Lyon-based clinical-stage #BioTech #startup aiming to prevent #cancer recurrence, has announced an €11 million extension to its Series A round, bringing its total #capital raised since #inception to €38 million. 🇫🇷 🧬 💉

https://t.co/3CHl9BbTMf
7
Sona ulaştın 🎉

Çerezler bu web sitesini normal bir şekilde kullanmana ve bu web sitesindeki deneyimini kişiselleştirmene olanak sağlar.

>>Daha fazla bilgi